People
Cillian King
Cillian King, PhD, is a QurAlis director and an EQT Life Sciences investor associated with its LSP Dementia Fund. His earlier career includes Swanbridge Capital and neuroscience research, with training at VU Amsterdam and MIT.
Roles
Muna Therapeutics
CurrentBoard Director
EQT
CurrentPartner — EQT Life Sciences (EQT group directory)
EQT Life Sciences
CurrentStrategy affiliation — Partner
QurAlis
CurrentBoard Member